IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 3 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,642 | -83.2% | 896 | -84.8% | 0.00% | -87.5% |
| Q2 2023 | $241,584 | +44637.8% | 5,888 | -61.1% | 0.01% | -52.9% |
| Q1 2023 | $540 | +96.4% | 15,119 | +107.9% | 0.02% | +54.5% |
| Q4 2022 | $275 | -99.9% | 7,272 | -38.1% | 0.01% | +37.5% |
| Q3 2022 | $520,000 | +881.1% | 11,755 | +722.0% | 0.01% | +700.0% |
| Q2 2022 | $53,000 | -83.6% | 1,430 | -83.6% | 0.00% | -66.7% |
| Q1 2022 | $323,000 | +773.0% | 8,728 | +611.9% | 0.00% | +200.0% |
| Q4 2021 | $37,000 | +37.0% | 1,226 | +54.2% | 0.00% | 0.0% |
| Q3 2021 | $27,000 | -93.3% | 795 | -92.2% | 0.00% | -90.9% |
| Q2 2021 | $406,000 | -26.7% | 10,183 | -17.4% | 0.01% | +22.2% |
| Q1 2021 | $554,000 | -42.2% | 12,323 | -27.3% | 0.01% | -69.0% |
| Q4 2020 | $958,000 | +13.5% | 16,943 | -4.8% | 0.03% | +222.2% |
| Q3 2020 | $844,000 | +2457.6% | 17,795 | +3153.2% | 0.01% | +800.0% |
| Q2 2020 | $33,000 | -90.7% | 547 | -92.7% | 0.00% | -95.5% |
| Q1 2020 | $354,000 | +6980.0% | 7,482 | +8914.5% | 0.02% | – |
| Q3 2019 | $5,000 | -95.8% | 83 | -95.5% | 0.00% | -100.0% |
| Q2 2019 | $119,000 | +5850.0% | 1,852 | +4773.7% | 0.01% | – |
| Q4 2018 | $2,000 | -97.8% | 38 | -97.9% | 0.00% | -100.0% |
| Q3 2018 | $93,000 | +210.0% | 1,805 | +147.3% | 0.01% | +250.0% |
| Q2 2018 | $30,000 | -93.4% | 730 | -92.9% | 0.00% | -94.9% |
| Q1 2018 | $455,000 | +1200.0% | 10,321 | +1424.5% | 0.04% | +875.0% |
| Q2 2017 | $35,000 | +400.0% | 677 | +289.1% | 0.00% | +300.0% |
| Q1 2017 | $7,000 | -92.5% | 174 | -91.1% | 0.00% | -90.0% |
| Q4 2016 | $93,000 | +1228.6% | 1,962 | +906.2% | 0.01% | +900.0% |
| Q3 2016 | $7,000 | -65.0% | 195 | -77.1% | 0.00% | -50.0% |
| Q2 2016 | $20,000 | +900.0% | 850 | +1973.2% | 0.00% | – |
| Q1 2016 | $2,000 | -91.7% | 41 | -89.4% | 0.00% | -100.0% |
| Q4 2015 | $24,000 | – | 385 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,529,838 | $404,393,000 | 11.39% |
| DOWLING & YAHNKE LLC | 676,379 | $41,888,000 | 5.27% |
| Opus Point Partners Management, LLC | 102,459 | $6,345,000 | 4.19% |
| WILLIAM HARRIS INVESTORS INC | 230,443 | $14,271,000 | 3.43% |
| PINNACLE ASSOCIATES LTD | 1,690,263 | $104,678,000 | 2.20% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 21,298 | $1,319,000 | 2.11% |
| Sonora Investment Management, LLC | 126,763 | $7,850,000 | 2.04% |
| Virtus ETF Advisers LLC | 10,447 | $647,000 | 1.78% |
| Apex Capital Management | 1,020,096 | $63,175,000 | 1.41% |
| PERKINS CAPITAL MANAGEMENT INC | 19,900 | $1,232,000 | 1.32% |